 | | Vol. 23.07 – 7 March, 2022 |
| |
|
|
| The authors purified human biliary epithelial cells from human livers that were not used for liver transplantation.
[Cell Stem Cell] |
|  |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| A rabies virus glycoprotein (RVG)-camouflaged gold yarnball that could boost the targeting efficiency at a brain tumor via dual hierarchy- and RVG-mediated spinal cord transportation, facilitating the decrease of tumor heterogeneity for T cell infiltration, was developed.
[ACS Nano] |
|
|
|
| Investigators treated three children suffering from severe, therapy-refractory GvHD with polyclonally expanded regulatory T cells generated from the original stem cell donor.
[Molecular Therapy] |
|
|
|
| Scientists described the generation of an array of monoclonal antibodies against cell surface markers that selectively label stem cell-derived islet cells.
[Stem Cell Reports] |
|
|
|
| The authors performed a phase I/IIa non-randomized, open-label study to evaluate safety and efficacy of a single, intravenous infusion of autologous, adipose-derived MSCs over a period of 52 weeks, in patients with active rheumatoid arthritis.
[Stem Cell Research & Therapy] |
|
|
|
| MSCs were comparable to N-acetylcysteine against acetaminophen (APAP)-induced liver failure by secreting hepatocyte growth factor with less regenerative retardation concerns, thus facilitating the application of MSCs in clinical therapy for APAP liver failure.
[Stem Cell Research & Therapy] |
|
|
|
| Abdominal adipose tissue-derived mesenchymal stem cell were harvested from patients without or with obesity during kidney donation or bariatric surgery, respectively.
[International Journal of Obesity] |
|
|
|
| Investigators developed targeted mesenchymal stem cell therapy for osteoarthritiscartilage using a cell-tissue matchmaking nanoconstruct.
[Scientific Reports] |
|
|
|
| Investigators provided an overview for the available management strategies for relapsed mantle cell lymphoma (MCL) and examines the role of CAR T cell in the current and future treatment of MCL.
[Therapeutic Advances in Hematology] |
|  |
|
|
|
| The field of heart regeneration has entered a renaissance period with remarkable progress in the understanding of endogenous heart regeneration, stem cell differentiation for exogenous cell therapy, and cell-delivery methods.
[Developmental Cell] |
|
|
|
| By harnessing the chemokine system and taking into consideration the chemokine expression profile in the tumor microenvironment, CAR-T cells may be homed into tumors to facilitate direct tumor cell cytolysis.
[Cell Reports Medicine] |
|
|
|
|
| The Yale Translational Research Imaging Center will be upgrading to a novel interventional cardiology ultrasound system, including 2D and 3D transthoracic, transesophageal, and high frequency vascular imaging probes.
[Yale School of Medicine] |
|
|
|
| Celyad Oncology SA announced it has taken the decision to voluntarily pause the CYAD-101-002 Phase Ib trial due to reports of two fatalities that presented with similar pulmonary findings.
[Celyad Oncology] |
|
|
|
|
| April 2 – April 3, 2022
Fukuoka, Japan, and Virtual |
|
|
|
|
|
| Institute of Cancer Research – London, England, United Kingdom |
|
|
|
| | BioNTech – Gaithersburg, Maryland, United States |
|
|
|
| | Friedrich Miescher Institute for Biomedical Research – Basel, Switzerland |
|
|
|
| | Singapore-MIT Alliance for Research and Technology (SMART) Centre – Singapore, Singapore |
|
|
|
| | Babraham Institute – Babraham, England, United Kingdom |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
